| Majd I Jaradat, MD | |
|
4907 S Collins St, Suite 101, Arlington, TX 76018-1156 | |
| (817) 375-0610 | |
| (817) 375-0640 |
| Full Name | Majd I Jaradat |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 33 Years |
| Location | 4907 S Collins St, Arlington, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245295989 | NPI | - | NPPES |
| 196443904 | Medicaid | TX | |
| 196443906 | Medicaid | TX | |
| P000789480 | Other | RAILROAD MEDICARE | |
| 7002130 | Other | TX | CIGNA |
| 7220017 | Other | TX | AETNA |
| 8AT814 | Other | TX | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 01046695 (Indiana) | Secondary |
| 207RN0300X | Internal Medicine - Nephrology | M5250 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Dialysis Care Of Grand Prairie | Grand prairie, TX | Dialysis facility |
| Taum Dialysis Llc | Arlington, TX | Dialysis facility |
| Heb Dialysis Center | Bedford, TX | Dialysis facility |
| North Arlington Dialysis | Arlington, TX | Dialysis facility |
| Hulen Dialysis | Fort worth, TX | Dialysis facility |
| Medical City Arlington | Arlington, TX | Hospital |
| Texas Health Arlington Memorial Hospital | Arlington, TX | Hospital |
| Methodist Mansfield Medical Center | Mansfield, TX | Hospital |
| Texas Health Heart & Vascular Hospital Arlington | Arlington, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ntkc-dfw, Pllc | 8820138464 | 6 |
News Archive
Current tools for combating malaria, such as artemisinin-based combination therapy (ACT) and increasing coverage of long-lasting insecticide treated nets (LLINs) insecticide-treated bednets (ITN) "could dramatically reduce the burden of malignant malaria on parts of Africa if a comprehensive, sustained intervention programme were in place," according to a study published this week in PLoS Medicine, CORDIS News reports.
In a paper recently uploaded to the bioRxiv* preprint server, structure-based ASOs are developed against SARS-CoV-2, intended to bond with RNA in its structured in situ form, rather than the more rarely encountered linear section, achieving greater affinity and specificity than linear ASOs, and demonstrating inhibition of virus replication in human cells.
Winner Medical Group Inc., a leading manufacturer of medical dressings, medical disposables and non-woven PurCotton materials for the medical and consumer products industries, announced today that it closed its previously announced public offering of 1,380,000 shares of common stock.
Extremely premature infants born at 22 to 25 weeks of gestation have low rates of survival, and many of those infants who live have severe or moderate neurodevelopmental impairments. Thus, clinicians and families face the extremely difficult decision to either provide active, potentially lifesaving treatment at birth, or just provide comfort care.
› Verified 1 days ago
| Entity Name | Ntkc-dfw, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467000828 PECOS PAC ID: 8820138464 Enrollment ID: O20091212000091 |
News Archive
Current tools for combating malaria, such as artemisinin-based combination therapy (ACT) and increasing coverage of long-lasting insecticide treated nets (LLINs) insecticide-treated bednets (ITN) "could dramatically reduce the burden of malignant malaria on parts of Africa if a comprehensive, sustained intervention programme were in place," according to a study published this week in PLoS Medicine, CORDIS News reports.
In a paper recently uploaded to the bioRxiv* preprint server, structure-based ASOs are developed against SARS-CoV-2, intended to bond with RNA in its structured in situ form, rather than the more rarely encountered linear section, achieving greater affinity and specificity than linear ASOs, and demonstrating inhibition of virus replication in human cells.
Winner Medical Group Inc., a leading manufacturer of medical dressings, medical disposables and non-woven PurCotton materials for the medical and consumer products industries, announced today that it closed its previously announced public offering of 1,380,000 shares of common stock.
Extremely premature infants born at 22 to 25 weeks of gestation have low rates of survival, and many of those infants who live have severe or moderate neurodevelopmental impairments. Thus, clinicians and families face the extremely difficult decision to either provide active, potentially lifesaving treatment at birth, or just provide comfort care.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Majd I Jaradat, MD 901 W Wall St, Suite 101, Grapevine, TX 76051-7414 Ph: (817) 488-6669 | Majd I Jaradat, MD 4907 S Collins St, Suite 101, Arlington, TX 76018-1156 Ph: (817) 375-0610 |
News Archive
Current tools for combating malaria, such as artemisinin-based combination therapy (ACT) and increasing coverage of long-lasting insecticide treated nets (LLINs) insecticide-treated bednets (ITN) "could dramatically reduce the burden of malignant malaria on parts of Africa if a comprehensive, sustained intervention programme were in place," according to a study published this week in PLoS Medicine, CORDIS News reports.
In a paper recently uploaded to the bioRxiv* preprint server, structure-based ASOs are developed against SARS-CoV-2, intended to bond with RNA in its structured in situ form, rather than the more rarely encountered linear section, achieving greater affinity and specificity than linear ASOs, and demonstrating inhibition of virus replication in human cells.
Winner Medical Group Inc., a leading manufacturer of medical dressings, medical disposables and non-woven PurCotton materials for the medical and consumer products industries, announced today that it closed its previously announced public offering of 1,380,000 shares of common stock.
Extremely premature infants born at 22 to 25 weeks of gestation have low rates of survival, and many of those infants who live have severe or moderate neurodevelopmental impairments. Thus, clinicians and families face the extremely difficult decision to either provide active, potentially lifesaving treatment at birth, or just provide comfort care.
› Verified 1 days ago
Dr. Waldo P Bracy Jr., M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1001 N Waldrop Dr, Ste. 509, Arlington, TX 76012 Phone: 817-394-4300 Fax: 817-394-0200 | |
Thang D Le, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 800 W Randol Mill Rd Ste 2300, Arlington, TX 76012 Phone: 866-202-1032 Fax: 817-548-6649 | |
Dr. Hujefa Yusuf Vora, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3150 Matlock Rd, Suite 403, Arlington, TX 76015 Phone: 817-784-0052 Fax: 817-375-5800 | |
Dr. Raza Askari, Nephrology Medicare: Accepting Medicare Assignments Practice Location: 515 W Mayfield Rd Ste 210, Arlington, TX 76014 Phone: 817-375-5847 | |
Thuc Quyen Thi Nguyen, Nephrology Medicare: Accepting Medicare Assignments Practice Location: 515 W Mayfield Rd, Suite 210, Arlington, TX 76014 Phone: 817-417-4027 Fax: 817-417-4043 | |
Dr. Bienvenido Gatmaitan Gatmaitan, Nephrology Medicare: Not Enrolled in Medicare Practice Location: 621 Matlock Centre Cir, Arlington, TX 76015 Phone: 817-860-6062 Fax: 817-795-6652 | |
Bernard A Mcgowen, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1217 Florida Dr, Suite 121, Arlington, TX 76015 Phone: 817-419-9155 Fax: 817-419-9412 |